Cargando…
Targeting TRAF3 Downstream Signaling Pathways in B cell Neoplasms
B cell neoplasms comprise >50% of blood cancers. However, many types of B cell malignancies remain incurable. Identification and validation of novel genetic risk factors and oncogenic signaling pathways are imperative for the development of new therapeutic strategies. We and others recently ident...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422099/ https://www.ncbi.nlm.nih.gov/pubmed/25960828 http://dx.doi.org/10.4172/1948-5956.1000327 |